The preeclampsia diagnostics market is expected to grow at a CAGR of 4.1% during the forecast period of 2025 to 2033, propelled by advancements in biomarker discovery, the impact of maternal age and lifestyle factors, and technological innovations in diagnostic imaging. However, the limited awareness and access to diagnostics in low-resource settings pose a critical restraint, highlighting the necessity for equitable healthcare solutions to address the global challenge of preeclampsia.
The cell lysis and disruption market is expected to grow at a CAGR of 10.3% during the forecast period of 2025 to 2033, driven by increasing demand in biotechnology research, technological advancements, and growing applications in drug discovery and development. Standardization and reproducibility present challenges that need to be addressed for the market to reach its full potential. The segmentation by technique highlights the dominance of reagent-based methods, while physical disruption methods exhibit the highest expected CAGR.
The rapid medical diagnostic kits market has witnessed remarkable growth in recent years, driven by the increasing demand for quick and accurate diagnostic solutions. The rapid medical diagnostic kits market is expected to grow at a CAGR of 9% during the forecast period of 2025 to 2033, fueled by the increasing emphasis on Point-of-Care Testing (POCT), global health threats, and advancements in diagnostic technologies. While challenges in test specificity and accuracy pose restraints, the market's segmentation provides valuable insights into the preferences and priorities of healthcare professionals and consumers.
The healthcare data annotation tools market is a critical component of the evolving healthcare technology landscape, playing a pivotal role in enhancing the quality and accuracy of healthcare data. The healthcare data annotation tools market is expected to grow at a CAGR of 27.7% during the forecast period of 2025 to 2033, driven by key drivers such as the surge in demand for Text Annotation Tools, the dominance of Image/Video Annotation Tools, and the rise in adoption of Automatic Annotation Technology.
miRNA, or microRNA, are small non-coding RNAs that play a vital role in the regulation of gene expression. The miRNA Sequencing and Assay market revolves around the technologies and methodologies employed to study these RNA molecules, which have been linked to various disease mechanisms and are often the subject of innovative therapeutic research. miRNA sequencing and assay market is estimated to grow at a CAGR of 13.1% from 2025 to 2033, driven by increasing significance in cancer research and technological advancements in RNA sequencing.
The transradial access devices market is expected to grow at a CAGR of 7.8% during the forecast period of 2025 to 2033 due to the increased adoption of harmful habits, such as alcohol use and smoking, and sedentary lifestyles. A large increase in cardiovascular disease incidences in developed and developing economies is anticipated to drive market growth. Moreover, according to a study published in the Journal of the American College of Cardiology, the prevalence of cardiovascular risk factors and disease is expected to rise dramatically in the United States by 2060.
The multiplex assay market is expected to experience a CAGR of 14.5% during the forecast period of 2025 to 2033, driven by the demand for efficient and high-throughput diagnostic solutions across various industries, including healthcare, pharmaceuticals, and research. Multiplex assays enable simultaneous detection of multiple analytes in a single assay, offering advantages such as cost-effectiveness, time efficiency, and reduced sample consumption. the multiplex assay market is poised for substantial growth due to technological advancements, rising prevalence of chronic and infectious diseases, and increased funding for life science research.
The market revenue for hyperspectral imaging iystems is expected to grow at a CAGR of 13.2% during the forecast period of 2025 to 2033, due to the growing adoption of this technology in precision agriculture and remote sensing applications. In precision agriculture, hyperspectral imaging helps farmers and agronomists assess crop health, detect diseases, and optimize resource management by providing precise and actionable information about crop conditions.
The sperm bank market is expected to witness a CAGR of 3.7% during the forecast period of 2025 to 2033, driven by factors such as increasing infertility rates, advancements in reproductive technologies, and growing awareness and acceptance of assisted reproductive procedures. In terms of an overview, a sperm bank is a facility that collects, processes, stores, and distributes donated sperm for use in assisted reproductive procedures, such as in vitro fertilization (IVF) and intrauterine insemination (IUI).
The blood transfusion diagnostics market is a critical segment of the healthcare industry that plays a crucial role in ensuring safe and efficient blood transfusion practices. The market is expected to grow at a CAGR of 7% during the forecast period of 2025 to 2033. This market is driven by the increasing demand for blood and blood products, rising awareness about transfusion-transmitted infections, and the need for accurate and efficient diagnostic methods.
The global market for diagnostic testing is expected to surpass US $350 billion by 2030, expanding at a CAGR of 9% from 2023 to 2030.
Diagnostic tests are medical examinations performed to aid in the recognition or diagnosis of any disease. These tests are crucial for the management, surveillance, and prevention of any disease. These tests increase patient care, customer security, and healthcare expenditures. According to the study Non-communicable Illnesses Important Statistics from the World Health Organization (WHO), chronic diseases will be responsible for approximately 41 million deaths annually by April 2021, or 71 percent of all deaths worldwide. Hence, diagnostic tests have proved beneficial in the prevention, identification, and diagnosis of disease, as well as in the management of chronic sickness situations. By detecting individual risk factors and early warning signs, clinical diagnostics create new opportunities for early prevention and intervention. Thus, it is projected that the industry as a whole would continue to expand as the prevalence of chronic diseases rises.
The industry is expected to be driven by the increasing popularity of decentralized healthcare systems. In addition, it is predicted that the market would expand during the forecast period as a result of leading market players' adoption of new innovations and technical advancements in the sector. As a result of these reasons, the market for point-of-care diagnostics is predicted to expand in the future years. The aging of the world's population increases the likelihood of contracting a variety of diseases, including diabetes, cancer, cardiovascular disease, obesity, and neurological disorders. The United Nations projects that by 2020, 727 million people worldwide would be 65 or older. In addition, it is estimated that by 2050, there will be more than 1.5 billion individuals aged 80 and older, which is twice as many as there are today. The predicted growth in the global elderly population during the forecast period is likely to have a substantial impact on the market.
Acute Market Reports, a market research and consulting company remains the best choice for industry participants in the diagnostics domain. Acute Market Reports' clients gain from our forward-thinking research technique, which aids in the development of well-informed business decisions. With the help of our extensive network of business partners, we are able to offer innovative strategic research solutions to our global clients.
